Back to Journals » Therapeutics and Clinical Risk Management » Volume 16

Original Research

Comparative Treatment Patterns and Outcomes of Fulvestrant versus Everolimus Plus Exemestane for Postmenopausal Metastatic Breast Cancer Resistant to Aromatase Inhibitors in Real-World Experience

       
Total article views   HTML views PDF downloads Totals
6,722 Dovepress* 6,119+ 1,014 7,133
PubMed Central* 603 165 768
Totals 6,722 1,179 7,901
*Since 30 June 2020
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar